scholarly journals The Impact of Legalizing Syringe Exchange Programs on Arrests Among Injection Drug Users in California

2007 ◽  
Vol 84 (3) ◽  
pp. 423-435 ◽  
Author(s):  
Alexis N. Martinez ◽  
Ricky N. Bluthenthal ◽  
Jennifer Lorvick ◽  
Rachel Anderson ◽  
Neil Flynn ◽  
...  
2005 ◽  
Vol 9 (4) ◽  
pp. 423-432 ◽  
Author(s):  
Laura M. Bogart ◽  
Alex H. Kral ◽  
Andrea Scott ◽  
Rachel Anderson ◽  
Neil Flynn ◽  
...  

2005 ◽  
Vol 32 (1) ◽  
pp. 27-34 ◽  
Author(s):  
Laura M. Bogart ◽  
Alex H. Kral ◽  
Andrea Scott ◽  
Rachel Anderson ◽  
Neil Flynn ◽  
...  

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Anneli Uusküla ◽  
Don C Des Jarlais ◽  
Mart Kals ◽  
Kristi Rüütel ◽  
Katri Abel-Ollo ◽  
...  

2001 ◽  
Vol 21 (5) ◽  
pp. 357-367 ◽  
Author(s):  
Harold A. Pollack

Objectives. Hepatitis C (HCV) has emerged as a major epidemic among injection drug users (IDUs), with observed prevalence exceeding 70% in many American and European cities. This article explores the potential of syringe exchange programs (SEPs) to reduce HCV incidence and prevalence. Design. A random-mixing epidemiological model is used to examine the potential impact of harm reduction interventions. Methods. Steady-state analysis is used to scrutinize the impact of SEP on HCV incidence and prevalence and to examine the accuracy of short-term incidence analysis in predicting long-run program effects. Results. SEP is predicted to have little impact on HCV incidence and prevalence within realistic populations of IDUs. Conclusions. Short-term incidence analysis substantially overstates SEP effectiveness and cost-effectiveness in preventing HCV. More comprehensive harm reduction models, coupled with referral of active IDUs to treatment, must complement syringe exchange to successfully contain highly infectious blood-borne diseases.


Sign in / Sign up

Export Citation Format

Share Document